When to Seek a Second Opinion for Chronic Pain and How to Read a Treatment Plan

Key Takeaways
- Chronic pain is defined by duration, more than three months, not by severity, and a plan written as if the problem were acute is itself a reason to ask for a review.
- A readable treatment plan contains five parts: a working diagnosis in plain words, functional goals, a mechanism and timeline for each therapy, named side effects, and a review date.
- The CDC guideline prefers nonopioid therapies for chronic pain and asks that opioid benefit and harm be reassessed within one to four weeks of starting, which a reviewer will check.
- Nerve-pain medicines from the antidepressant and anti-seizure classes typically need a few weeks before a fair judgment, so a plan that dropped them after days has not tested them.
- Most second opinions in chronic pain confirm the direction and adjust the details; confirmation by two independent clinicians is evidence the plan is reasonable.
- Switching clinicians is always allowed, but it should be a handover with overlapping prescribing, because several pain medicines should never be stopped abruptly.
Seek a second opinion for chronic pain when pain has lasted more than three months without a clear working diagnosis, when a plan has gone weeks without review, when surgery or long-term opioid therapy is proposed, or when you cannot explain the plan's goals in your own words. A readable treatment plan states the diagnosis, measurable function goals, how each therapy works, its expected timeline, side effects to watch, and a review date.
The folder sits on the kitchen table, thicker than it was in spring: two MRI reports, a physical therapy discharge summary, a printout of a medication list with three names crossed out. Pain in the lower back and right leg has been there for fourteen months. The last appointment lasted eleven minutes and ended with a procedure booked, but nobody said what the procedure was expected to change.
That is the moment most people start searching for the phrase second opinion chronic pain. Not because they distrust their doctor, but because they can no longer explain to their spouse what the plan is for. The phrase feels adversarial. In practice it is a review, and reviews are ordinary medicine.
This explainer covers two linked skills: knowing when a fresh set of eyes is worth asking for, and reading any treatment plan, old or new, closely enough to tell whether it is actually a plan or just a list.
What a second opinion for chronic pain actually is, and how it works
A second opinion is a formal review of your diagnosis and treatment plan by a clinician who was not involved in the original decisions. It is not a replacement doctor, a referral for a procedure, or a vote on whether your first team was wrong. The reviewing clinician reads what already exists, examines you, asks their own questions, and writes an assessment that goes back to you and usually to the referring team.
In chronic pain the review looks at four things. First, the working diagnosis: which structure, nerve pathway or process is thought to be driving the pain, and how confident the evidence is. Second, whether the tests done so far actually answer that question or merely describe findings that many pain-free adults also carry. Third, the treatments tried, at what intensity and for how long, because a therapy abandoned after a week has not really been tested. Fourth, the plan going forward and whether it matches guideline-level recommendations.
The mechanics are simple. Records, imaging and medication history are gathered. You attend one or two appointments, sometimes by video. The reviewer may order nothing new, or may suggest a test that would change the decision. A written summary follows. You then take that summary back to the team that holds your prescriptions and your care, and the three of you decide together.
Chronic pain is defined by the Cleveland Clinic and MedlinePlus as pain lasting longer than three months, past the point where injured tissue would normally have healed. That definition matters here: a second opinion on a six-week problem is usually premature, while one on a six-year problem that has never had a clear explanation is often overdue.
Do I have chronic pain? Why the definition shapes the plan
People ask this question far more often than clinicians expect, and the honest answer is that the label depends on time, not severity. Pain that persists or recurs for more than three months is, by the standard definition used in MedlinePlus and the Cleveland Clinic patient material, chronic. Pain that stops a person from working or doing most daily activities on most days is called high-impact chronic pain. In the United States, CDC survey data show that about 20.9 percent of adults reported chronic pain and 6.9 percent reported high-impact chronic pain in the most recent published estimate.

The distinction matters because chronic pain behaves differently from acute pain. Acute pain is a warning from damaged tissue: the signal is useful, it fades as healing happens, and treatment aims at the injury. Chronic pain often continues after tissue has recovered. The nervous system can become sensitized, meaning nerves fire more readily and the brain amplifies ordinary signals. That is a mechanism, not a character flaw, and it explains why an MRI can look unremarkable while the pain is real and disabling.
A treatment plan written for acute pain looks like a short course of rest, a medicine, a follow-up. A plan written for chronic pain looks like a program: movement, sleep, mood, pacing of activity, medicines chosen for their effect on nerve signaling rather than inflammation alone, and occasionally a procedure aimed at a specific nerve or joint.
So the question to put to any plan is: was this written for the problem I actually have? If you are past the three-month mark and the plan still reads as if you sprained something last week, that mismatch is itself a reason to ask for a review. Diagnosis remains the job of your clinician; the timeline is simply the context you bring to the conversation.
When to seek a second opinion for chronic pain, and who is usually asked to wait
Some triggers are nearly universal in guideline-based practice. A proposed surgery for pain, particularly spine surgery, is the classic one, because the decision is hard to reverse. A plan that moves toward long-term opioid therapy is another: the CDC clinical practice guideline recommends that benefits and harms be weighed carefully before starting and reassessed within one to four weeks, and a reviewing clinician can check that nonopioid options were genuinely explored first. A diagnosis that has changed three times, or never been stated at all, is a third.
Softer triggers matter too. You have been told nothing more can be done. The plan has not been revisited in months even though nothing has improved. A therapy was stopped because of side effects and nothing replaced it. Your questions are answered with a shrug or a printout. None of these mean your care is bad; each means the thinking deserves a fresh look.
Who is usually asked to wait? Someone whose pain began under three months ago and whose plan already includes a review date. Someone two weeks into a therapy that typically needs several weeks to show an effect. Someone who has a planned follow-up next week where exactly these questions can be raised. A second opinion gathered before the first plan has been given a fair trial tends to produce the same advice in a different voice.
Timing also has a practical side. Imaging and records need to travel with you, and a review is most useful when it can compare a plan against outcomes, which requires the plan to have run long enough to produce any. Patience here is not resignation. It is making sure the review has something to review.
How to read a treatment plan: the five parts every plan should have
Hand a plan to an experienced pain clinician and they will scan for five elements. If any are missing, the document is a list of appointments, not a plan.
The working diagnosis comes first, written in words you can repeat. “Lumbar radiculopathy from a left L5 disc herniation” tells you a nerve root is being irritated by a disc. “Chronic low back pain, nonspecific” tells you the team has looked for a single structural cause and not found one, which is an honest and common conclusion. Either is fine. “Back pain” alone is not a diagnosis.
Goals come second, and they should be about function, not a pain score. Walking twenty minutes, sleeping through most nights, returning to part-time work: these can be measured. A target of “less pain” cannot, and plans built around pain scores alone tend to escalate treatments without anyone noticing whether life is improving.
Third, each therapy should be paired with its mechanism in one plain sentence and the timeline over which a fair judgment can be made. Mayo Clinic patient guidance notes that medicines borrowed from the antidepressant and anti-seizure families, used for nerve pain, often take a few weeks to show benefit. A plan that stops them after five days has not tested them.
Fourth, side effects and risks, named rather than implied, with a note on which ones mean stop and call. Fifth, a review date and a stated next step for each branch: if this helps, we continue; if it does not, we move to that.
Read your own plan against this checklist tonight. The gaps you find are the questions for your next appointment, and if the gaps are large, they are the case for a review.
Common chronic pain treatments: mechanism, timeline and what to watch
The table below is a reading aid, not a menu. It summarizes how the main categories of treatment in a typical chronic pain plan are thought to work and the sort of window in which they are usually judged, so that you can tell whether a plan has given each one a fair trial. The specific choice always sits with your treating team.

| Approach | How it is thought to work | Window for a fair judgment | Typical things to watch |
|---|---|---|---|
| Graded exercise and physical therapy | Rebuilds tolerance in deconditioned tissue and reduces nervous system sensitivity through repeated, non-threatening movement | Weeks of consistent sessions, per NHS self-management guidance | Short flare after sessions is common; worsening weakness or numbness is not |
| Psychological therapies such as cognitive behavioral therapy | Changes how the brain interprets and responds to pain signals, and improves sleep and pacing | A course of sessions over weeks | Low mood deepening rather than lifting |
| Nerve-pain medicines (antidepressant and anti-seizure classes) | Dampen overactive pain signaling in nerves and spinal cord | A few weeks, per Mayo Clinic guidance | Drowsiness, dizziness, mood change; never stopped abruptly without advice |
| Anti-inflammatory and simple analgesics | Reduce inflammatory chemicals or alter pain perception | Days to short weeks | Stomach, kidney and blood-pressure effects with prolonged use |
| Opioids | Act on opioid receptors to reduce perceived pain | CDC guideline: reassess benefit and harm within 1–4 weeks of starting | Sedation, constipation, tolerance, dependence; prescriber-led changes only |
| Injections and nerve procedures | Deliver anti-inflammatory medicine or interrupt a specific nerve’s signal | Your team should state the expected window before the procedure | Fever, new weakness, severe headache after a spinal procedure |
Notice what the table does not contain: a cure column, a success percentage, or a ranking. Evidence for chronic pain treatments is often modest and mixed, and guideline bodies generally recommend combining several approaches rather than betting on one.
Medicines in a treatment plan: mechanism and timelines, not promises
Medication is where plans most often lose readers, because the list grows and the reasoning disappears. A readable plan attaches a purpose to every name on it.
Start with the classes rather than the brands. Anti-inflammatory medicines reduce the chemical messengers that make injured tissue hurt; they suit flare-ups more than months of continuous use, because stomach, kidney and cardiovascular effects accumulate. Certain antidepressants, used at the discretion of the prescriber, change the balance of signaling chemicals in the spinal cord and brain, which is why they help some nerve pain regardless of mood. Anti-seizure medicines quiet nerves that fire too readily. Opioids act on receptors throughout the nervous system to lower perceived pain, and the CDC guideline is explicit that nonopioid therapies are preferred for subacute and chronic pain, with opioids considered only when expected benefits for both pain and function outweigh risks.
Timelines are the second thing to look for. Mayo Clinic patient guidance describes the nerve-pain classes as typically taking a few weeks to show benefit, with the prescriber adjusting over that period. A plan that lists a medicine without saying when you will know whether it is working has skipped the part that lets you judge it.
Third, the exit route. Every medicine should have a sentence on what happens if it does not help or is not tolerated. The CDC guideline warns against abrupt discontinuation of long-term opioids, and the same caution applies to several nerve-pain classes. That is why nothing in this article, and nothing in a second opinion letter, should be read as instruction to start, stop or change a medicine yourself. The reviewer advises; the prescriber decides with you.
If your current list has names you cannot explain, write them down and ask, one by one, what each is for and how long it has been given to work.
Injections and procedures: what a plan should explain before you agree
Procedures are the part of a pain plan most likely to be booked quickly and understood slowly. An epidural steroid injection places anti-inflammatory medicine near an irritated nerve root in the spine. A facet joint injection or medial branch block targets the small joints at the back of the spine or the tiny nerves that supply them. Radiofrequency ablation uses heat to interrupt a nerve’s signal for a period. Each is a legitimate tool. Each also has a narrow question it is meant to answer.
That is the first thing to read for: what question is this procedure asking? Some injections are diagnostic as much as therapeutic. If a block of a particular nerve removes the pain for the expected few hours, the team learns that nerve is involved; if it does nothing, they learn something equally useful. A plan should say which of these it is.
Second, the expected window of benefit. Relief from injections is temporary by design and varies widely between people and conditions. The plan should state the range your team expects and what will happen at the end of it. Repeated injections without a stated purpose, or without any functional goal attached, is a pattern a second opinion will flag.
Third, risks in plain words. Most are minor: soreness, a brief flare, temporary numbness. Rare serious ones after spinal procedures include infection, bleeding and nerve injury, which is why the red-flag list later in this article includes fever, severe headache and new weakness after a procedure.
Fourth, the alternative. Guideline-level care treats procedures as one component alongside movement and psychological approaches, not as the plan itself. If a procedure is the only line on the page, ask what sits around it.
How to get a second opinion for chronic pain: records, imaging and the ask
The ask is the part people dread, and it is usually the easiest part. A direct sentence works: “I would like a second opinion on this plan before we go further. Can you help me arrange it?” Most clinicians hear this regularly. Many health systems and insurers have a formal pathway, and some will require a referral from your current team, so starting the conversation with them is practical as well as polite.
Gathering records is the real work. The reviewer needs the original imaging files, not just the written reports, because the report describes what one radiologist noticed and the images let another clinician look for themselves. Request them on disc or through a patient portal. Collect clinic notes, physical therapy summaries, procedure reports and a full medication history including things that were tried and stopped, with the reason. Add your own one-page timeline: when the pain started, what changed it, what you can and cannot do now.
Choosing the reviewer is less about reputation and more about fit. If the open question is surgical, a surgeon who was not involved in the first recommendation is the right reader. If the question is whether the whole approach is sound, a pain medicine specialist or a multidisciplinary pain program, where physicians, physical therapists and psychologists assess together, tends to give the most complete review.
Video consultations are now common for this purpose and can be adequate when the question is about reading existing evidence; they are less suited to questions that depend on a physical examination.
Finally, tell the reviewer what you want from them. “Is the diagnosis solid?” and “Would you recommend this surgery?” are different questions and produce different letters.
Can I switch pain management doctors without losing continuity of care?
Yes, and the fact that this question is typed into search engines so often suggests how uneasy people feel asking it out loud. Changing clinicians is permitted everywhere, and it is not the same as getting a second opinion: a second opinion keeps your current team in charge while adding advice, whereas a switch transfers your care.
The caution is about continuity, not permission. Chronic pain care often involves prescriptions that cannot safely stop on the day a relationship ends. The CDC guideline specifically warns that abruptly stopping long-term opioid therapy carries risks, and several nerve-pain medicines also need prescriber-managed changes. A switch therefore works best as a handover: the new clinician is identified and has agreed to take you on, records have moved, and the outgoing team continues prescribing until the first appointment with the new one. Ask both sides to confirm that overlap in writing.
There are also reasons to pause before switching. If the relationship is strained because the plan is not working, a second opinion may fix the plan without the disruption of a new team learning your history. If a clinician has declined to escalate a particular medicine, that is often a guideline-driven decision rather than a personal one, and a new clinician is likely to reach the same position. Switching to find a different answer to the same question tends to disappoint.
Good reasons do exist: repeated dismissal of your concerns, a plan that has not changed in a year despite no progress, or simple logistics such as a move. In each case the goal is the same: an orderly transfer, with no gap in prescribing and every record arriving before you do. The decision about treatment still belongs to the team you end up with, whoever that is.
What the following weeks usually look like after a second opinion
The letter arrives, and it rarely says what people braced for. Most second opinions in chronic pain confirm the broad direction and suggest adjustments: a therapy restarted at an adequate intensity, a medicine class not yet tried, a psychological component added, a procedure deferred until something else has been given its window. Outright reversal of a diagnosis happens, but it is the exception, and a plan that is broadly confirmed is still useful, because now two independent clinicians have reached it.
The first task is a three-way conversation. Bring the letter to your treating team. Where the two views agree, the plan simply continues with more confidence. Where they differ, ask each side to explain their reasoning in terms of the evidence rather than preference. Disagreement between competent clinicians usually means the evidence is genuinely mixed, which is common in chronic pain, and the deciding factor becomes your own priorities: how much risk you accept, how much you can commit to a program, what function matters most.
The next stretch is a fair trial of whatever is chosen. Using the windows discussed earlier, that typically means weeks rather than days before anyone judges. Keep a short log: a line a day on what you did and how you slept. This is not homework for its own sake; it is the only data the team will have at the review.
Then the review date, which the revised plan should carry explicitly. Expect flares along the way. The NHS self-management guidance describes them as a normal part of chronic pain, to be planned for rather than treated as failure. What matters at the review is the trend over the whole window, not the worst day in it.
What people often get wrong about second opinions and pain plans
The first myth is that asking offends the doctor. Clinicians request second opinions on their own cases, discuss them in team meetings, and generally welcome a colleague’s view on a difficult problem. A clinician who reacts badly to the request is telling you something about the relationship, not about the request.
The second is that more imaging equals more answers. Degenerative findings on spine MRI are present in many adults without pain, and a scan cannot show sensitization of the nervous system at all. A second opinion that recommends no new tests is often the better one; it has read the existing evidence closely enough to know what another picture would and would not change.
The third is that a second opinion is a search for a yes. Someone who has been told a procedure is not advisable, or that a stronger medicine is not appropriate, sometimes seeks a reviewer who will say otherwise. Where guidelines are clear, as with the CDC position that nonopioid therapies are preferred for chronic pain, a careful reviewer will say the same thing.
The fourth is that a good plan eliminates pain. Guideline bodies frame chronic pain care around managing symptoms and restoring function, because for many conditions complete relief is not a realistic target and plans built on that target lead to escalation. A plan that aims at walking further and sleeping better is not a lesser plan.
The fifth is that nothing changed, so the review failed. Confirmation has value. Two clinicians arriving at the same place, independently, is evidence that the plan is reasonable, and it often makes the hardest part, committing to it fully for the weeks it needs, easier to do.
What not to say to a pain management doctor, and what to say to someone in chronic pain
Two search queries sit side by side here, and both are really about communication under strain.
With a pain clinician, the phrases that tend to derail an appointment are the ones that close the conversation before it opens. “Nothing works” leaves the clinician without data; “the exercises made it worse for a day so I stopped” is far more useful. “I just need something stronger” frames the visit as a negotiation about a single lever, when guideline-based care has many. “I read that this procedure fixes it” invites a debate about a website rather than about you. None of these are wrong to feel. They are simply less effective than describing function: what you could do six months ago, what you can do now, what you want back.
Equally, there is nothing to hide. Alcohol, other medicines, supplements, low mood, fear of movement: all of these change what a safe plan looks like, and clinicians are not grading your honesty. The CDC guideline explicitly asks prescribers to consider the whole picture, which they cannot do if parts are missing.
With a friend or relative in chronic pain, the unhelpful phrases are the ones that minimize or prescribe. “But you look fine” and “have you tried yoga” land as doubt. “My cousin had that and surgery sorted it” sets up a comparison nobody can live up to. What tends to help is specific and practical: “Would it be easier if I drove?” or “Do you want to talk about it or be distracted from it today?” Chronic pain is invisible and tiring to explain. Believing the person, and asking rather than advising, is most of the job.
Questions to ask your care team about a chronic pain treatment plan
Bring these on paper. A ten-minute appointment goes further when the questions are already written, and the answers you record become part of the next review.
- What is my working diagnosis, in one sentence, and how confident are you in it?
- Which findings on my imaging matter, and which are common in people without pain?
- What functional goals is this plan built around, and how will we measure them?
- For each medicine on my list: what is it for, how is it thought to work, and when will we know whether it is helping?
- What is the plan if a therapy does not help or I cannot tolerate it?
- If a procedure is proposed: is it diagnostic, therapeutic or both, what window of benefit do you expect, and what happens after it?
- What are the serious warning signs that should make me call rather than wait for the review?
- When is the review date, and who will I see?
- Would a multidisciplinary pain program, combining physical and psychological approaches, be appropriate for me?
- Would you be comfortable arranging a second opinion on this plan, and which part of it do you think most deserves another view?
That last question is the one people skip, and it is the one that most often changes the tone of the relationship. Clinicians who are confident in a plan usually say so and offer to help. Clinicians who have doubts of their own often welcome the opening. Either way, the decisions that follow stay where they belong: with you and the team treating you, now better informed.
When to call your doctor: red-flag signs that should not wait for a review
Everything above assumes time to think. Some symptoms remove that time, and a second opinion is the wrong tool for them. Seek urgent care, or call emergency services, if any of the following appear, whether or not you are mid-way through a treatment plan.
- New weakness in a leg or arm, a foot that drags, or numbness spreading rather than staying put.
- Loss of bladder or bowel control, or numbness in the area that would touch a saddle. These can indicate compression of the nerves at the base of the spine and are treated as an emergency.
- Fever, chills or a rapidly worsening headache after a spinal injection or any procedure, or redness and swelling at the site.
- Back or neck pain following a fall or accident, particularly in older adults or anyone with weakened bones.
- Pain that wakes you consistently from sleep and is accompanied by unexplained weight loss, night sweats or a history of cancer.
- Chest pain, breathlessness or pain spreading to the jaw or arm, which should never be assumed to be musculoskeletal.
- Severe drowsiness, confusion or slowed breathing in anyone taking opioids or sedating nerve-pain medicines, which the CDC guideline lists among the serious harms of these classes.
- Thoughts of harming yourself. Chronic pain and low mood travel together, and this is a medical emergency with help available.
Short of an emergency, call your treating team within the day if a new symptom appears that was not on the plan’s list of expected effects, or if you feel a prescribed medicine is not safe for you. Do not stop it on your own; ask. The clinicians who wrote your plan would far rather hear from you early than read about the complication at the review.
Frequently asked questions
Do I have chronic pain if it comes and goes?
Pain that persists or keeps returning for more than three months meets the standard definition of chronic pain used by MedlinePlus and the Cleveland Clinic, even if some days are better than others. Severity is not part of the definition. Whether a specific condition explains it is a question for your clinician, but the timeline alone justifies a plan built for persistent pain rather than a short-term injury.
How do I get a second opinion for chronic pain without upsetting my current doctor?
Ask directly and early: say you would like another view on the plan and ask them to help arrange it. Most clinicians request second opinions themselves and hear the question often. Request your imaging files and notes, write a one-page timeline, and tell the reviewer which decision you want assessed. The reviewer’s letter then comes back to your treating team for a shared discussion.
Can I switch pain management doctors while taking prescribed medicines?
Yes, but plan it as a handover rather than a break. Several chronic pain medicines, including opioids and some nerve-pain classes, should not be stopped abruptly, and the CDC guideline warns against sudden discontinuation. Confirm the new clinician has accepted you, move your records, and ask the outgoing team to continue prescribing until your first new appointment so there is no gap.
What not to say to a pain management doctor?
Avoid phrases that close the conversation, such as “nothing works” or “I just need something stronger,” and replace them with specifics about function: what you could do before, what you can do now, what you want back. Be complete about alcohol, other medicines, mood and fear of movement, because a safe plan depends on the whole picture, and clinicians are not grading your honesty.
What should a good chronic pain treatment plan include?
A working diagnosis you can repeat in a sentence, goals measured in function rather than pain scores, each therapy paired with how it works and when it can fairly be judged, named side effects with the serious ones flagged, and a review date with a stated next step if the therapy does not help. If any of these is missing, the document is a list of appointments rather than a plan.
Is a second opinion worth it if the first plan is already working a little?
Often not yet. If function is improving and a review date exists, the plan is doing its job and a second opinion is more likely to echo it. The time to ask is when a plan has run its window without progress, when a surgery or long-term opioid therapy is proposed, or when the diagnosis has never been clearly stated.
Will a second opinion mean more scans?
Not necessarily, and a reviewer who orders none has often read the existing evidence more carefully. Degenerative findings on spine imaging are common in adults without pain, and scans cannot show nervous system sensitization. New tests are warranted only when the result would change a decision, which the reviewer should be able to explain.
How long before I know whether a nerve-pain medicine is helping?
Mayo Clinic patient guidance describes medicines from the antidepressant and anti-seizure families, used for nerve pain, as typically taking a few weeks to show benefit, with the prescriber adjusting during that period. The exact window and any changes belong to your prescribing clinician; a plan should state the window in advance so you know when the judgment will be made.
What to say to someone in chronic pain?
Believe them and ask rather than advise. Specific offers such as “would it help if I drove” or “do you want to talk about it or be distracted today” land better than suggestions of treatments or comparisons with other people’s recoveries. Chronic pain is invisible and exhausting to explain; not having to justify it is, for many people, the most useful support.
What if the second opinion disagrees with my treating team?
Bring both views to one conversation and ask each side to explain the evidence behind their position. In chronic pain, disagreement between competent clinicians usually reflects genuinely mixed evidence, and the deciding factors become your own priorities: how much risk you accept, how much you can commit, and which functions matter most. The final decision rests with you and the team that treats you.
References
- CDC: Chronic Pain Among Adults in the United States (MMWR)
- CDC: Clinical Practice Guideline for Prescribing Opioids for Pain
- MedlinePlus: Chronic Pain
- Cleveland Clinic: Chronic Pain
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
More from the Blog
Questions to Ask Before Neuromodulation: Trials, Device Life and What Follow-Up Involves
Before agreeing to neuromodulation, ask what the trial will measure and what result counts as a pass, how the permanent device is implanted, how…
How Long Does Relief From an Epidural Injection Usually Last and What Affects It?
Relief from an epidural steroid injection usually begins within a few days and, when it works, commonly lasts from several weeks to a few…
Interventional Pain Management vs Spine Surgery: When a Needle Comes Before a Scalpel
Interventional pain management uses image-guided injections, nerve blocks or radiofrequency treatments to calm or interrupt a pain source without cutting; spine surgery removes or…
Diagnostic Nerve Blocks: How a Temporary Block Helps Find the Source of Your Pain
A diagnostic nerve block is a short-acting local anesthetic injected near a specific nerve to test whether that nerve carries your pain. If the…
The Day After an Epidural Injection: Soreness, a Brief Pain Flare and Getting Back to Activity
Mild soreness at the injection site and a short-lived increase in pain are common in the first one to three days after an epidural…
Spinal Cord Stimulator Recovery: Bending and Lifting Limits, Wound Checks and Programming
Spinal cord stimulator recovery usually means walking on the day of surgery, keeping incisions dry and inspected daily, and avoiding bending, twisting and lifting…






